Aarkstore Enterprise-Staphylococcus Aureus Infections – Pipeline Review, H1 2012 || Market Research latest report

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Staphylococcus Aureus Infections – Pipeline Review, H1 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Staphylococcus Aureus Infections - Pipeline Review, H1
2012, provides an overview of the Staphylococcus Aureus Infections therapeutic
pipeline. This report provides information on the therapeutic development for
Staphylococcus Aureus Infections, complete with latest updates, and special features
on late-stage and discontinued projects. It also reviews key players involved in the
therapeutic development for Staphylococcus Aureus Infections. Staphylococcus
Aureus Infections - Pipeline Review, H1 2012 is built using data and information
sourced from Global Markets Direct’s proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together by
Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Staphylococcus Aureus Infections.
- A review of the Staphylococcus Aureus Infections products under development by
companies and universities/research institutes based on information derived from
company and industry-specific sources.
- Coverage of products based on various stages of development ranging from

2. discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Table of contents:
List of Tables 13
List of Figures 15
Introduction 16
Global Markets Direct Report Coverage 16
Staphylococcus Aureus Infections Overview 17
Therapeutics Development 18
An Overview of Pipeline Products for Staphylococcus Aureus Infections 18
Staphylococcus Aureus Infections Therapeutics under Development by Companies
20
Staphylococcus Aureus Infections Therapeutics under Investigation by
Universities/Institutes 26
Late Stage Products 28
Comparative Analysis 28
Mid Clinical Stage Products 29
Comparative Analysis 29
Early Clinical Stage Products 30
Comparative Analysis 30
Discovery and Pre-Clinical Stage Products 31
Comparative Analysis 31
Staphylococcus Aureus Infections Therapeutics – Products under Development by
Companies 32
Staphylococcus Aureus Infections Therapeutics – Products under Investigation by
Universities/Institutes 38
Companies Involved in Staphylococcus Aureus Infections Therapeutics
Development 39
Bristol-Myers Squibb Company 39
United Therapeutics Corporation 40
GlaxoSmithKline plc 41
Genentech, Inc. 42

3. Takeda Pharmaceutical Company Limited 43
Ceragenix Pharmaceuticals, Inc. 44
Piramal Healthcare Limited 45
Rib-X Pharmaceuticals, Inc. 46
Achillion Pharmaceuticals, Inc. 47
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1
2012&PubId=&pagenum=1
Bacteremia – Pipeline Review, H1 2012
Staphylococcus Aureus Infections – Pipeline Review, H1 2012
Warts – Pipeline Review, H1 2012
Mixed Dyslipidemia – Pipeline Review, H1 2012
Gastroenteritis – Pipeline Review, H1 2012
Hypereosinophilic Syndrome – Pipeline Review, H1 2012
Familial Adenomatous Polyposis Coli – Pipeline Review, H1 2012

4. Tinnitus – Pipeline Review, H1 2012
Shock – Pipeline Review, H1 2012
Influenza B Infections – Pipeline Review, H1 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com